INVOKAMET XR

Serial Number 86277042
Registration 5134045
701

Registration Progress

Application Filed
May 9, 2014
Under Examination
Dec 9, 2014
Approved for Publication
Oct 14, 2014
Published for Opposition
Oct 14, 2014
Registered
Jan 31, 2017

Trademark Image

INVOKAMET XR

Basic Information

Serial Number
86277042
Registration Number
5134045
Filing Date
May 9, 2014
Registration Date
January 31, 2017
Published for Opposition
October 14, 2014
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
701
Status Date
Jun 3, 2023
Registration
Registered
Classes
005

Rights Holder

JOHNSON & JOHNSON

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

JOHNSON & JOHNSON

Original Applicant
03
New Brunswick, NJ

JOHNSON & JOHNSON

Owner at Publication
03
New Brunswick, NJ

JOHNSON & JOHNSON

Original Registrant
03
New Brunswick, NJ

Legal Representation

Attorney
Cheryl Foytlin

USPTO Deadlines

Next Deadline
560 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2017-01-31)
Due Date
January 31, 2027
Grace Period Ends
July 31, 2027

Application History

44 events
Date Code Type Description Documents
Jun 3, 2023 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED Loading...
Jun 3, 2023 15AK O REGISTERED - SEC. 15 ACKNOWLEDGED Loading...
Jun 3, 2023 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Loading...
Jun 3, 2023 NA15 E SEC. 15 ACKNOWLEDGEMENT - E-MAILED Loading...
Jun 2, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 23, 2022 ES8R I TEAS SECTION 8 RECEIVED Loading...
Nov 23, 2022 E15R I TEAS SECTION 15 RECEIVED Loading...
Jan 31, 2022 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 31, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 29, 2016 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 28, 2016 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 8, 2016 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 24, 2016 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 24, 2016 IUAF S USE AMENDMENT FILED Loading...
Jun 14, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 11, 2016 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 9, 2016 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 9, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 9, 2016 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 28, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 27, 2015 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 27, 2015 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 11, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 11, 2015 EXT2 S SOU EXTENSION 2 FILED Loading...
May 12, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 8, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 8, 2015 EXT1 S SOU EXTENSION 1 FILED Loading...
May 8, 2015 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 9, 2014 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 14, 2014 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 14, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 24, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 11, 2014 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 10, 2014 ALIE A ASSIGNED TO LIE Loading...
Aug 27, 2014 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 27, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 27, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 27, 2014 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 27, 2014 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 18, 2014 CNRT F NON-FINAL ACTION MAILED Loading...
Aug 15, 2014 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 15, 2014 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 21, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 13, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceuticals for the prevention or treatment of metabolic diseases
First Use Anywhere: Sep 26, 2016
First Use in Commerce: Sep 26, 2016

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"XR"